Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

692 public trials 117 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

Biennial CEM in Women With a Personal History of Breast Cancer

NCT06105749

Conditions
Breast Cancer, Breast Cancer Female, Breast Diseases, +5 more
Locations
  • UPMC Magee-Womens Imaging - Bethel Park Bethel Park, Pennsylvania, United States
  • UPMC Magee at the Lemieux Sports Complex Cranberry Township, Pennsylvania, United States
  • Magee Womancare Monroeville Monroeville, Pennsylvania, United States
  • Magee-Womens Hospital Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NCT06312176

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Ironwood Cancer & Research Centers ( Site 0066) Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center-Oncology ( Site 0004) Gilbert, Arizona, United States
  • Providence Medical Foundation-Oncology ( Site 0020) Fullerton, California, United States
  • Moores Cancer Center ( Site 0059) La Jolla, California, United States
View all 259 locations
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

NCT06966700

Conditions
Breast Diseases, Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, +6 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0066) Gilbert, Arizona, United States
  • Mayo Clinic Cancer Center ( Site 0034) Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0035) Tucson, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center ( Site 0055) Burbank, California, United States
View all 319 locations
View Trial Details
Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

NCT07060807

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Southern Cancer Center (SCC) ( Site 8000) Daphne, Alabama, United States
  • The University of Arizona Cancer Center - North Campus ( Site 0055) Tucson, Arizona, United States
  • Los Angeles Hematology Oncology Medical Group ( Site 0026) Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian ( Site 0025) Newport Beach, California, United States
View all 198 locations
View Trial Details
Recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

NCT07214532

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
View all 48 locations
View Trial Details
Recruiting

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

NCT05573893

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Research Site Amberg, Germany
  • Research Site Ansbach, Germany
  • Research Site Apolda, Germany
  • Research Site Aschaffenburg, Germany
View all 109 locations
View Trial Details
Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

NCT06926868

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Local Institution - 0303 Hot Springs, Arkansas, United States
  • Helios Clinical Research Cerritos, California, United States
  • Local Institution - 0307 Cerritos, California, United States
  • Local Institution - 0308 Cerritos, California, United States
View all 295 locations
View Trial Details
Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View all 32 locations
View Trial Details
Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

NCT07287098

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology/Oncology - Parkside Santa Monica, California, United States
View all 86 locations
View Trial Details

Related conditions